A Agilent Technologies Inc.

Agilent Technologies Showcases Innovative Laboratory Solutions at analytica China 2016

Agilent Technologies Inc. (NYSE:A) will showcase its latest innovations at analytica China 2016, the leading Chinese exhibition for laboratory technology, analysis, biotechnology and diagnostics, in Shanghai, Oct. 10–12, 2016. These innovations are industry-leading and are designed to meet the specific needs of the markets Agilent serves, including China.

“We innovate with a purpose—our solutions are designed to improve the science and the economics of the laboratory,” said Patrick Kaltenbach, president of Agilent’s Life Sciences and Applied Markets Group. “For example, our instruments are built with the industry’s top technology, yet designed for ease of use and efficiency, and our software unifies the lab with multi-technique, and multi-vendor capabilities. With every innovation, Agilent’s goal is to deliver the trusted answers and insights customers need to realize superior outcomes.”

Featured Agilent innovation excels customers’ operational excellence:

The recently introduced Agilent Intuvo 9000 GC System will be a feature at analytica China 2016. This innovative solution makes sophisticated gas chromatography (GC) technology easy to use with click-and-run connections that eliminate ferrules, Guard-Chip technology that extends column life, and a trim-free column that eliminates retention time shifts due to column trimming maintenance. The Intuvo 9000 is ideal for high-throughput contract laboratories, and for labs dealing with difficult sample matrices, in fields such as food, environment, chemical and forensics testing. Customers throughout the world, including China, anticipated these types of operational advancements, and Agilent delivered. With a 50-year history in GC, Agilent is the market leader; and China is the home of the company’s largest GC production line.

Additional Agilent solutions on display that deliver operational excellence include:

  • The Agilent 4210 Microwave Plasma-Atomic Emission (MP-AES) Spectrometer, which enables remote elemental analysis. This flexibility opens up new possibilities for applications such as on-site process stream monitoring, as well as river-water and source-water monitoring—one of the key focus areas of China’s 13th Five-Year Plan.
  • The latest version of Agilent OpenLAB Chromatography Data System (CDS) Software, which makes complex data analysis simpler, and enables laboratories to manage their entire workflow on a single screen. With advances such as Peak Explorer, additional insights into data sets are revealed that help customers reach critical decisions faster.
  • Agilent AdvanceBio Size Exclusion Chromatography (SEC) Columns, which deliver excellent peak shape to help biopharma companies achieve reproducible results when analyzing monoclonal antibodies.

Another highlight of analytica China 2016 will be next-generation sequencing. Agilent solutions presented will include sample quality control and automated library preparation. NGS has revolutionized variant analysis by providing single-molecule sensitivity, enabling the detection of rare alleles and those of low frequency, even within highly heterogeneous samples.

Innovations that enhance laboratory efficiency:

Agilent will also demonstrate solutions that improve laboratory efficiency through high performance, reliability and robustness:

  • The Agilent 1260 Infinity II Liquid Chromatography (LC) System, which provides easy column handling and superior sample logistics to ensure fast turnaround times and high instrument utilization.
  • The Agilent 5110 Inductively Coupled Plasma-Optical Emission Spectrometry (ICP-OES) System that incorporates unique Dichroic Spectral Combiner (DSC) technology, enabling axial and radial view analysis at the same time.
  • The second-generation Agilent 8900 Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) System with controlled-reaction chemistry that delivers the lowest detection limits for previously difficult elements such as sulfur, silicon and phosphorus. This system also includes a fast detector that sets a new benchmark for single nanoparticle applications.
  • The Agilent 7010B Triple Quadrupole Gas Chromatography/Mass Spectrometry System that enhances efficiency with the inclusion of Agilent’s patented JetClean self-cleaning ion source. JetClean significantly reduces—or even eliminates—the need for source cleaning.
  • Agilent will also showcase a new application kit that enables food-testing laboratories to quickly screen for 189 veterinary drugs regulated by the Chinese Ministry of Agriculture. Additionally, Agilent continues to provide diversified services that improve the digital experience for customers. Recent enhancements include a new China online store that will enable easier purchasing, as well as new online services and learning functionality via WeChat and App.

Representatives from the Agilent CrossLab Group will participate in analytica China 2016 to discuss the full range of Agilent’s laboratory solutions, including Laboratory Business Intelligence, Laboratory Equipment Management, RFID for Inventory Management and more.

“Today, we are even more focused on our customers,” said Mark Doak, president of Agilent CrossLab Group. “We’re partnering with customers to better understand their laboratory and workflow needs, develop and design customized solutions, and deliver differentiated consumables, services and consultative support. We believe these investments in China will enable our customers to achieve better economic, operational and scientific outcomes.”

Visit Agilent Technologies Inc. at analytica China 2016 at booth numbers N1.1610 and N2.2102.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.04 billion in fiscal 2015 and employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.

EN
10/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agilent Technologies Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approva...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ , a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the technology, was applied in developing and validating AUCATZYL. The xCELLigence RTCA technology supported the development and implementation of the potency assay. By providing precise and reliable cell analysis solutions, Agilent assisted Autolus in achieving the high standards required for FDA approval. Dr. Xiaobo Wang, Vice President and General Manager of the Cell Functio...

 PRESS RELEASE

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025 (NYSE: A) is excited to announce its participation at the upcoming , which will be held March 22-27, 2025, in Boston. At the conference, Agilent will highlight innovative digital pathology solutions designed to enhance diagnostic accuracy and efficiency. In pathology, Agilent offers comprehensive tissue diagnostic solutions for analyzi...

 PRESS RELEASE

Agilent Research Catalyst Award Presented to Columbia University for P...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced that has received an Agilent Research Catalyst (ARC) Award on behalf of , an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy. Dr. Muranski is the Director of Cellular Immunotherapy Laboratory at Columbia University Irving Medical Center. He is also an Assistant Professor of Medicine at Columbia University Medical Center, a principal investigator at the Columbia Center for Translational Immunology (CCTI), and a member of the Herbert Irv...

 PRESS RELEASE

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Com...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- (NYSE: A) today announced its kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and previously untreated advanced melanoma patients. These two new indications bring the total indications launched in Europe for PD-L1 IHC 28-8 pharmDx to nine. PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the advanced staining solution. Lung cancer and malignant melanoma are major healthcare concerns worldwide, with lung cancer accountin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch